---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-036776"
form_type: "8-K"
ticker: "ANNA"
cik: "0001845123"
company_name: "AleAnna, Inc."
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T01:28:01.662086+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Swiftmerge Acquisition Corp. terminates merger with HDL Therapeutics by mutual agreement

## Summary
- Merger agreement dated August 11, 2023 terminated as of February 14, 2024.
- No termination fee or other payment due to either party under the Mutual Termination Agreement.
- All parties released each other from any and all claims arising under the merger agreement.
- Confidentiality obligations between Swiftmerge and HDL Therapeutics survive the termination.
- Swiftmerge must now pursue an alternative business combination or face potential liquidation.

## SEC filing metadata
- accession: 0001193125-24-036776
- form_type: 8-K
- ticker: ANNA
- cik: 0001845123
- company_name: AleAnna, Inc.
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845123/000119312524036776/0001193125-24-036776-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845123/000119312524036776/d628914d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-036776
- JSON: https://secwatch.observer/filing/0001193125-24-036776.json
- Plain text: https://secwatch.observer/filing/0001193125-24-036776.txt

## Key facts
- Material Agreements
  AleAnna, Inc. terminated Merger Agreement and Mutual Termination Agreement with HDL Therapeutics, Inc., and IVCP Merger Sub, Inc. valued at Mutual termination of Merger Agreement; no termination fee. (effective 2024-02-14).
  - Action: termination
  - Agreement: merger
  - Counterparty: HDL Therapeutics, Inc., and IVCP Merger Sub, Inc.
  - Value: Mutual termination of Merger Agreement; no termination fee.
  - Effective: 2024-02-14
  source text: On February 14, 2024, the Company, HDL and Merger Sub entered into a Mutual Termination Agreement (the “ Mutual Termination Agreement ”) pursuant to which they terminated the Merger Agreement by mutual agreement in accordance with Section 10.1(d) thereof, and each party, on behalf of itself and its agents, released, waived and forever discharged the other parties and their agents of and from any and all obligation or liability arising under the Merger Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845123/000119312524036776/0001193125-24-036776-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.